Literature DB >> 25186187

Kidney: polycystic kidney disease.

Binu M Paul1, Gregory B Vanden Heuvel.   

Abstract

Polycystic kidney disease (PKD) is a life-threatening genetic disorder characterized by the presence of fluid-filled cysts primarily in the kidneys. PKD can be inherited as autosomal recessive (ARPKD) or autosomal dominant (ADPKD) traits. Mutations in either the PKD1 or PKD2 genes, which encode polycystin 1 and polycystin 2, are the underlying cause of ADPKD. Progressive cyst formation and renal enlargement lead to renal insufficiency in these patients, which need to be managed by lifelong dialysis or renal transplantation. While characteristic features of PKD are abnormalities in epithelial cell proliferation, fluid secretion, extracellular matrix and differentiation, the molecular mechanisms underlying these events are not understood. Here we review the progress that has been made in defining the function of the polycystins, and how disruption of these functions may be involved in cystogenesis.
© 2014 The Authors. WIREs Developmental Biology published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25186187      PMCID: PMC4423807          DOI: 10.1002/wdev.152

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Dev Biol        ISSN: 1759-7684            Impact factor:   5.814


  154 in total

1.  Polycystic kidney disease: a new perspective from the beginning.

Authors:  Theodore I Steinman
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

Review 2.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

3.  Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1.

Authors:  Ellian Wang; Hsiu-Mei Hsieh-Li; Yuan-Yow Chiou; Yi-Lin Chien; Hua-Hui Ho; Hsian-Jean Chin; Chi-Kuang Leo Wang; San-Chi Liang; Si-Tse Jiang
Journal:  J Pathol       Date:  2010-11       Impact factor: 7.996

Review 4.  mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression.

Authors:  Tobias B Huber; Gerd Walz; E Wolfgang Kuehn
Journal:  Kidney Int       Date:  2010-11-17       Impact factor: 10.612

5.  The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

Authors:  F Qian; T J Watnick; L F Onuchic; G G Germino
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

6.  Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction.

Authors:  M Albert Basson; Simge Akbulut; Judy Watson-Johnson; Ruth Simon; Thomas J Carroll; Reena Shakya; Isabelle Gross; Gail R Martin; Thomas Lufkin; Andrew P McMahon; Patricia D Wilson; Frank D Costantini; Ivor J Mason; Jonathan D Licht
Journal:  Dev Cell       Date:  2005-02       Impact factor: 12.270

7.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

8.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

Review 9.  Murine models of polycystic kidney disease: molecular and therapeutic insights.

Authors:  Lisa M Guay-Woodford
Journal:  Am J Physiol Renal Physiol       Date:  2003-12

10.  Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4α as a disease modifier.

Authors:  Luis F Menezes; Fang Zhou; Andrew D Patterson; Klaus B Piontek; Kristopher W Krausz; Frank J Gonzalez; Gregory G Germino
Journal:  PLoS Genet       Date:  2012-11-29       Impact factor: 5.917

View more
  24 in total

1.  Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.

Authors:  Binu Porath; Safia Livingston; Erica L Andres; Alexandra M Petrie; Joshua C Wright; Anna E Woo; Carol G Carlton; Richard Baybutt; Gregory B Vanden Heuvel
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-12

2.  Analysis of mutations in six Chinese families with autosomal dominant polycystic kidney disease.

Authors:  Hanlu Wang; Sen Dai; Jianhui Zhang; Yi Li; Yumian Gan; Tao Lu; Yaobin Zhu; Jiabin Wu; Ning Lin; Faqiang Tang; Jiewei Luo
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

3.  Guiding Cell Network Assembly using Shape-Morphing Hydrogels.

Authors:  John M Viola; Catherine M Porter; Ananya Gupta; Mariia Alibekova; Louis S Prahl; Alex J Hughes
Journal:  Adv Mater       Date:  2020-06-24       Impact factor: 30.849

4.  Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease.

Authors:  Hila Milo Rasouly; Sudhir Kumar; Stefanie Chan; Anna Pisarek-Horowitz; Richa Sharma; Qiongchao J Xi; Yuriko Nishizaki; Yujiro Higashi; David J Salant; Richard L Maas; Weining Lu
Journal:  Kidney Int       Date:  2016-08-31       Impact factor: 10.612

Review 5.  Therapeutic Targets in Polycystic Liver Disease.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Nicholas F LaRusso
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

6.  Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.

Authors:  Kyle Jansson; Jessica Venugopal; Gladis Sánchez; Brenda S Magenheimer; Gail A Reif; Darren P Wallace; James P Calvet; Gustavo Blanco
Journal:  J Membr Biol       Date:  2015-08-20       Impact factor: 1.843

Review 7.  GLIS1-3 transcription factors: critical roles in the regulation of multiple physiological processes and diseases.

Authors:  Anton M Jetten
Journal:  Cell Mol Life Sci       Date:  2018-05-19       Impact factor: 9.261

8.  Pathologic Lesions of the Budgett Frog (Lepidobatrachus laevis), an Emerging Laboratory Animal Model.

Authors:  Mandy A Womble; Gregory A Lewbart; Heather R Shive
Journal:  Comp Med       Date:  2020-03-31       Impact factor: 0.982

9.  Mapping kidney tubule diameter ex vivo by diffusion MRI.

Authors:  Darya Morozov; Neda Parvin; Jennifer R Charlton; Kevin M Bennett
Journal:  Am J Physiol Renal Physiol       Date:  2021-03-15

Review 10.  New Insights into the Molecular Mechanisms Targeting Tubular Channels/Transporters in PKD Development.

Authors:  Ming Wu; Shengqiang Yu
Journal:  Kidney Dis (Basel)       Date:  2016-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.